Retrotransposons in Schizophrenia
Retrotransposons in Schizophrenia
批准号:
8703800
负责人:
Wade H Berrettini
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-18 至 2015-06-30
关键词:
AdolescenceAffectAllelesAttenuatedAutopsyBehaviorBiological AssayBrainBrain DiseasesCardiovascular DiseasesCell physiologyCellsChronicCognitiveCopy Number PolymorphismDNADataDaughterDelusionsDetectionDevelopmentDiseaseElectroencephalographyElementsEmbryonic DevelopmentEventFamily StudyFunctional disorderGene ExpressionGenesGeneticGenomeGenomicsGoalsHallucinationsHeritabilityHigh-Throughput Nucleotide SequencingHuman GenomeIndividualInheritedInterneuronsIntronsJunk DNALife ExpectancyLong Interspersed Nucleotide ElementsLuciferasesMorbidity - disease rateMosaicismMutationNeurodevelopmental DisorderNeuronal DifferentiationNeuronsOdds RatioOrganismParvalbuminsPaste substancePathogenesisPatientsPersonsPharmaceutical PreparationsPharmacotherapyPopulationPrefrontal CortexPsychotic DisordersPublic HealthPyramidal CellsRNARNA-Directed DNA PolymeraseRegulationReporterRestRetrotransposonRiskSample SizeSchizophreniaSourceSuicideSymptomsTestingTissuesTwin StudiesVariantWithdrawalbasedisabilitydisorder riskendonucleasegene functiongenome wide association studyhippocampal pyramidal neuronimprovedlaser capture microdissectionmortalityneuroimagingnovelpromoterpublic health relevanceresearch studysocialsolution hybridizationtransposon/insertion element
中文摘要
描述(由申请人提供):精神分裂症(SZ)是一种常见的慢性精神病性脑部疾病,影响1%的美国人口,由于相关的残疾、发病率和死亡率,造成了严重的公共卫生问题。SZ的发病机制知之甚少,但它被认为是一种神经发育障碍。神经影像学证据已经积累表明,背外侧前额叶皮层功能异常,在SZ,无论是在激活和休息。此外,EEG证据已经确定SZ中的振荡异常,表明皮质锥体神经元的小白蛋白阳性GABA能中间神经元调节功能障碍。在过去的5年中,积累的数据证明神经元胚胎发生伴随着LINE 1(L1)逆转录转座子(RTP)的激活,达到了意想不到的程度,使得每个发育中的神经元可以积累多个从头L1 RTP基因组插入,可能多达~80个。这导致CNS神经元群体内的大量镶嵌现象。虽然大多数这些体细胞从头L1 RTP插入对神经元功能几乎没有影响(也许是因为它们发生在基因沙漠或大内含子或该细胞功能不需要的基因中),但有些可能会干扰正常的神经元活动,因为它们已经插入到特定神经元正常功能所需的基因中。如果一个或多个功能性L1 RTP插入事件发生在CNS发育的早期,则所有源自该神经元前体的子神经元也将携带L1插入,可能导致注定增加SZ风险的神经元功能障碍群体。该提案将采用SZ患者和匹配对照的CNS组织(尸检时获得)。使用激光捕获显微切割小白蛋白阳性中间神经元及其背外侧前额叶皮质的靶锥体细胞,然后进行高通量测序,将完成新的L1 RTP插入的检测。以这种方式,预计将发现增加SZ风险的新的体细胞L1 RTP插入。
英文摘要
DESCRIPTION (provided by applicant): Schizophrenia (SZ) is a common, chronic group of psychotic brain disorders, affecting 1% of the US population, creating a significant public health problem because of the associated disability, morbidity and mortality. The pathogenesis of SZ is poorly understood, but it is thought to be a neurodevelopmental disorder. Neuroimaging evidence has accumulated to indicate that the dorsolateral prefrontal cortex functions abnormally in SZ, both when activated and at rest. Further, EEG evidence has identified abnormalities of ¿ oscillations in SZ, suggesting that parvalbumin positive GABAergic interneuron regulation of cortical pyramidal neurons is dysfunctional. In the past 5 years, data have accumulated to prove that neuronal embryogenesis is accompanied by activation of LINE1 (L1) retrotransposons (RTPs) to an unexpected degree, such that each developing neuron may accumulate multiple de novo L1 RTP genomic insertions, perhaps as many as ~80. This results in a substantial mosaicism within populations of CNS neurons. While most of these somatic de novo L1 RTP insertions will have little effect on neuronal function (perhaps because they occur in gene deserts or in large introns or in genes not required for that cell's function), some may interfere with normal neuronal activity because they have inserted into a gene needed by that particular neuron for normal function. If one or more functional L1 RTP insertion events occur early in CNS development, all the daughter neurons that derive from that neuronal precursor will also carry the L1 insertion, perhaps leading to a dysfunctional population of neurons destined to increase risk for SZ. This proposal will employ CNS tissue (obtained at autopsy) from SZ patients and matched controls. Using laser capture microdissection of parvalbumin positive interneurons and their target pyramidal cells of dorsolateral prefrontal cortex, followed by high-throughput sequencing, detection of novel L1 RTP insertions will be accomplished. In this manner, it is expected that novel somatic L1 RTP insertions, which increase risk for SZ, will be discovered.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical and Genetic Study of Prescription Opioid Addiction
-
批准号:9405766
-
项目类别:
-
资助金额:$84.52万
-
财政年份:2017
-
负责人:Wade H Berrettini
-
依托单位:
Clinical and Genetic Study of Prescription Opioid Addiction
-
批准号:10180929
-
项目类别:
-
资助金额:$73.73万
-
财政年份:2017
-
负责人:Wade H Berrettini
-
依托单位:
Retrotransposons in Schizophrenia
-
批准号:9886270
-
项目类别:
-
资助金额:$51.87万
-
财政年份:2016
-
负责人:Wade H Berrettini
-
依托单位:
Mobile DNA in Drug Abuse
-
批准号:9128371
-
项目类别:
-
资助金额:$46.34万
-
财政年份:2016
-
负责人:Wade H Berrettini
-
依托单位:
Retrotransposons in Schizophrenia
-
批准号:9127614
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2016
-
负责人:Wade H Berrettini
-
依托单位:
Temporal Lobe Epilepsy and Retrotransposons
-
批准号:9064579
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2015
-
负责人:Wade H Berrettini
-
依托单位:
Pharmacogenetics of Opioid Agonist Therapy
-
批准号:8628541
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2014
-
负责人:Wade H Berrettini
-
依托单位:
Cocaine Addiction and Retrotransposons
-
批准号:8623126
-
项目类别:
-
资助金额:$19.93万
-
财政年份:2013
-
负责人:Wade H Berrettini
-
依托单位:
Cocaine Addiction and Retrotransposons
-
批准号:8534432
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2013
-
负责人:Wade H Berrettini
-
依托单位:
Retrotransposons in Schizophrenia
-
批准号:8546544
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:Wade H Berrettini
-
依托单位:
Genetics of Nicotine Dependence
-
批准号:8418635
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2009
-
负责人:Wade H Berrettini
-
依托单位:
Genetics of Nicotine Dependence
-
批准号:8018531
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2009
-
负责人:Wade H Berrettini
-
依托单位:
Genetics of Nicotine Dependence
-
批准号:7781400
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2009
-
负责人:Wade H Berrettini
-
依托单位:
Genetics of Nicotine Dependence
-
批准号:8214668
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2009
-
负责人:Wade H Berrettini
-
依托单位:
Genetics of Nicotine Dependence
-
批准号:7651053
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2009
-
负责人:Wade H Berrettini
-
依托单位:
Mu Opioid Receptor in Addiction
-
批准号:7588275
-
项目类别:
-
资助金额:$84.4万
-
财政年份:2008
-
负责人:Wade H Berrettini
-
依托单位:
Mu Opioid Receptor in Addiction
-
批准号:7884442
-
项目类别:
-
资助金额:$84.18万
-
财政年份:2008
-
负责人:Wade H Berrettini
-
依托单位:
Mu Opioid Receptor in Addiction
-
批准号:7690774
-
项目类别:
-
资助金额:$84.93万
-
财政年份:2008
-
负责人:Wade H Berrettini
-
依托单位:
Administrative Core
-
批准号:7595565
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2008
-
负责人:Wade H Berrettini
-
依托单位:
Mu Opioid Receptor in Addiction
-
批准号:8101354
-
项目类别:
-
资助金额:$81.54万
-
财政年份:2008
-
负责人:Wade H Berrettini
-
依托单位:
海外基金